1. [1] P. C. Em, V. V. Lenh, N. V. Cuong, N. D. Ngoc Thoi and L. T. Tuong Vi, “Formulation development, optimization, in vivo antidiabetic effect and acute toxicity of directly compressible herbal tablets containing Merremia tridentata (L.) extract,” J. Drug Deliv. Sci. Technol., vol. 84, p. 104445, 2023. DOI: 10.1016/j.jddst.2023.104445.
2.
[2] P. C. Em, V. V. Lenh, N. V. Cuong, N. D. Ngoc Thoi, L. T. Tuong Vi and T. N. Tuyen, “In vitro and in vivo antidiabetic activity, isolation of flavonoids, and in silico molecular docking of stem extract of Merremia tridentata (L.),” Biomed Pharmacother., vol. 146, p. 112611, 2022. DOI: 10.1016/j.biopha.2021.112611.
3.
[3] J. Muazu, S. Lame, G. T. Mohammed and S. J. Madu, “Formulation and tableting properties of aqueous extract of fresh ginger (Zingiber officinale) rhizome,” World J. Pharma. Res., vol. 4, pp. 9-18, 2015.
4.
[4] S. M. Ghurghure, M. S. A. Pathan, P. R. Surwase, P. D. Shirure and P. M. Gote, “Formulation and evaluation of chewable tablets containing aqueous extract of Zingiber officinale,” World J. Pharm. Pharmaceu. Sci., vol. 8, pp. 1-10, 2019.
5.
[5] USP USP44-NF39, United State Pharmacopoeia 44 - National Formulary 39, the United States Pharmacopeial Convention, Inc, Rockville, MD, 2021.